Filing Details

Accession Number:
0001702626-17-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-31 14:43:39
Reporting Period:
2016-08-24
Filing Date:
2017-03-31
Accepted Time:
2017-03-31 14:43:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
946644 Hemispherx Biopharma Inc HEB Biological Products, (No Disgnostic Substances) (2836) 520845822
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1702626 Stewart Appelrouth 999 Ponce De Leon Blvd., Suite 625
Coral Gables FL 33134
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-24 15,750 $2.21 15,750 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Shares and prices have been adjusted to give retroactive effect to the 1 for 12 reverse stock split effected on 8/29/16.
  2. This transaction was executed in multiple trades at prices ranging from $2.16 to $2.22. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.